IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that investigators shared new positive data for its DeCidE1 (DPX-Survivac with low dose Cyclophosphamide and Epacadostat) clinical trial at the 2019 American Society for...
Trial in Progress Poster to be Presented Today at the 2019 American Society of Clinical Oncology Annual Meeting Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today...
Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC). OCTIC is a shared platform where all information about...
TEL AVIV, Israel, June 03, 2019 (GLOBE NEWSWIRE) — VBL Therapeutics (VBLT), today announced that MRI data from VB-111 Phase 2 and Phase 3 studies in recurrent GBM (rGBM), presented yesterday at the 2019 American Society of Clinical Oncology (ASCO) annual...
New Trial Biosimulates Efficacy of Cancer Therapies Using Molecular Genetic Aberration Data 2019 ASCO Annual Meeting – Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced the Cellworks...
TM-B1 demonstrates 80% accuracy vs. 50% accuracy for current gold standard Todos Medical to attend 2019 ASCO Annual Meeting in Chicago, IL REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (TOMDF) (http://www.Todosmedical.com) today...
Email
Text